Abstract: The present invention provides a pharmaceutical and/or veterinary composition comprising a retard release formulation of a Solarium glaucophyllum preparation. The composition further preferably comprises a calcium source. The composition of the invention is suitable to prevent and/or treat hypocalcaemia. Furthermore, the composition is suitable to prevent milk fever in cows. Advantageously, the composition is administered only once before calving so as to prevent the occurrence of mil fever in cows.

Abstract: The present invention relates to the preparation of an enriched and equilibrated plant extract from Solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin D3, glycosides and flavonols, particularly quercetin glycosides. The present invention particularly describes a method for preparation of such a plant extract either in industrial or in laboratory scale. The present invention furthermore describes the use of such a plant extract or similar (synthetic) compositions for the prevention and treatment of bone mass reduction-related diseases, such as Osteopenia or Osteoporosis, for the prevention and treatment of Tibial Dyschondroplasis, preferably in poultry, for the treatment of milk fever, and is a dietary supplement for human and veterinary use.

Abstract: The present invention provides a pharmaceutical and/or veterinary composition comprising a retard release formulation of a Solarium glaucophyllum preparation. The composition further preferably comprises a calcium source. The composition of the invention is suitable to prevent and/or treat hypocalcaemia. Furthermore, the composition is suitable to prevent milk fever in cows. Advantageously, the composition is administered only once before calving so as to prevent the occurrence of mil fever in cows.

Abstract: The present invention relates to the preparation of an enriched and equilibrated plant extract from Solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin D3, glycosides and flavonols, particularly quercetin glycosides. The present invention particularly describes a method for preparation of such a plant extract either in industrial or in laboratory scale. The present invention furthermore describes the use of such a plant extract or similar (synthetic) compositons for the prevention and treatment of bone mass reduction-related diseases, such as Osteopenia or Osteoporosis, for the prevention and treatment of Tibial Dyschondroplasis, preferably in poultry, for the treatment of milk fever, and is a dietary supplement for human and veterinary use.

Abstract: The present invention relates to the preparation of an enriched and equilibrated plant extract from Solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin D3 glycosides and flavonols, particularly quercetin glycosides. The present invention particularly describes a method for preparation of such a plant extract either in industrial or in laboratory scale. The present invention furthermore describes the use of such a plant extract or similar (synthetic) compositions for the prevention and treatment of bone mass reduction-related diseases, such as Osteopenia or Osteoporosis, for the prevention and treatment of Tibial Dyschondroplasia, preferably in poultry, for the treatment of milk fever, and as a dietary supplement for human or veterinary use.

Abstract: The present invention provides a pharmaceutical and/or veterinary composition comprising a retard release formulation of a Solarium glaucophyllum preparation. The composition further preferably comprises a calcium source. The composition of the invention is suitable to prevent and/or treat hypocalcaemia. Furthermore, the composition is suitable to prevent milk fever in cows. Advantageously, the composition is administered only once before calving so as to prevent the occurrence of milk fever in cows.

Abstract: A method is provided for preventing or treating bone or musculoskeletal metabolism disorders or kidney malfunction in humans. It comprises providing to a subject in need of that a calcium containing or calcium enriched diet combined with the administration of an efficient amount of a plant extract of Solatium glaucophyllum comprising from about 0.8 to about 2.2 weight % of a mixture of 1,25-dihydroxyvitamin D3 glycosides and quercetin glycosides present in a ratio of about 1:100 to 1:200 parts by weight. There are also provided food or dietary composition and food supplement designed for preventing or treating bone or musculoskeletal metabolism disorders or kidney malfunction in humans which comprises an efficient amount of the said plant extract of Solanum glaucophyllum and a source of calcium.

Abstract: The present invention relates to the preparation of an enriched and equilibrated plant extract from Solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin D3 glycosides and flavonols, particularly quercetin glycosides. The present invention particularly describes a method for preparation of such a plant extract either in industrial or in laboratory scale. The present invention furthermore describes the use of such a plant extract or similar (synthetic) compositions for the prevention and treatment of bone mass reduction-related diseases, such as Osteopenia or Osteoporosis, for the prevention and treatment of Tibial Dyschondroplasia, preferably in poultry, for the treatment of milk fever, and as a dietary supplement for human or veterinary use.

Abstract: Nucleic acid sequences coding for a protein having ?,?-carotene 15,15?-monooxygenase activity and their uses in diagnostics, the synthesis of vitamin A and methods for the introduction of the ?,?-carotene 15,15?-monooxygenase cDNA into host cells are disclosed.

Abstract: Nucleic acid sequences coding for a protein having ?,?-carotene 15,15? enzyme activity and their uses in diagnostics, the synthesis of vitamin A and methods for the introduction of the ?,?-carotene 15,15? enzyme cDNA into host cells are disclosed.

Abstract: Nucleic acid sequences coding for a protein having &bgr;,&bgr;-carotene 15,15′ enzyme activity and their uses in diagnostics, the synthesis of vitamin A and methods for the introduction of the &bgr;,&bgr;-carotene 15,15′ enzyme cDNA into host cells are disclosed.

Abstract: Nucleic acid sequences coding for a protein having &bgr;,&bgr;-carotene 15,15′-monooxygenase activity and their uses in diagnostics, the synthesis of vitamin A and methods for the introduction of the &bgr;,&bgr;-carotene 15,15′-monooxygenase cDNA into host cells are disclosed.

Abstract: A composition for oxidative dyeing of hair is disclosed, having at least one compound of the general formula ##STR1## wherein X is CH.sub.2, O, S, NH, NR', CH(OH), CHR', CH(NH.sub.2), or CH(CH.sub.3),Y is O, NH,Z is O, S, NH,R is H, OH, R', OR', NR'.sub.2, NO.sub.2, halogen, andR' is an alkyl group with one to five carbon atoms.

Abstract: A raking apparatus comprises a guide track, a carriage supported on the guide track for displacement thereon along a traveling path, a linkage assembly supported on the carriage and comprising a plurality of linkage levers articulated to one another by respective joints, and a rake supported on the carriage and operatively connected to the linkage assembly for varying angular positions of the rake by the linkage assembly upon pivotal motion of the levers with respect to one another. There is further provided a slide track receiving one of the joints for guiding it upon pivotal motion of the levers and a locking mechanism mounted on the carriage and cooperating with the linkage assembly. The locking mechanism has a released position permitting a pivotal motion of the levers and a locking position immobilizing the levers of the linkage assembly with respect to one another.

Abstract: Use is made in the oxidative dyeing of hair of a preliminary coloring stage of the general formula ##STR1## wherein R signifies COOR', CONH.sub.2, CONHR', CONR'.sub.2, CONH--NH.sub.2, CONH--OH, CN, CH.sub.2 OH, CHO, CH(OH)(OR'), CH(OR').sub.2 and R' represents an alkyl group with 1 to 5 carbon atoms. The preliminary coloring stages as per formula (I) may be contained in the hair dyeing agents singly or in a mixture with known preliminary coloring stages and/or direct-acting hair dyeing agents. The hair dyeing agents may, in particular, additionally contain amino acids present in nature, their esters and/or their amides. The hair dyeing agents as described, are well compatible physiologically and it will particularly be brown to reddish-brown colorings having a natural effect, that may be obtained by their use.